Results 31 to 40 of about 859,888 (229)

Transcatheter Tricuspid Valve Replacement for Recurrent Tricuspid Regurgitation After Tricuspid Transcatheter Edge-to-Edge Repair

JACC: Case Reports
Background It is currently unknown whether tricuspid valve replacement with EVOQUE is feasible after tricuspid transcatheter edge-to-edge repair. Case Summary An 81-year-old patient with a complex history of multivalvular heart disease, previously ...
Denizhan Ozdemir, Jair Basantes de la Calle, D. Patel, Hasan Jilaihawi, Aakriti Gupta, Moody M. Makar, Raj R. Makkar   +6 more
semanticscholar   +3 more sources

Tricuspid Transcatheter-Edge-to-Edge-Repair and Transcatheter Tricuspid Valve Replacement for Tricuspid Regurgitation: Patient Profiles and Outcomes

CJC Open
Background Transcatheter tricuspid valve replacement (TTVR) is typically reserved for patients in whom tricuspid valve transcatheter edge-to-edge repair (T-TEER) is deemed unsuitable or unlikely to provide effective treatment. Comparative data evaluating
J. Jelisejevas, Brian Chiang, A. Husain, G. Sathananthan, Robert Moss, P. Blanke, J. Leipsic, J. Sathananthan, G. M. Cioffi, M. Togni, Stéphane Cook, D. Lim, A. Cheung, J. Webb, David A. Wood, Robert Boone   +15 more
semanticscholar   +3 more sources

Expanding the Tools for Transcatheter Tricuspid Valve Intervention: Transcatheter Tricuspid Valve Repair. [PDF]

JACC Case Rep, 2020
[Figure: see text]
Taramasso M.
europepmc   +4 more sources

Transcatheter tricuspid valve repair: early experience in the Netherlands. [PDF]

Neth Heart J, 2021
Abstract Background Symptomatic tricuspid regurgitation (TR) is increasingly prevalent and impairs quality of life and survival, despite medical treatment. Transcatheter tricuspid valve repair (TTVR) has recently become available as a treatment option for patients not eligible for tricuspid valve surgery.
Meijerink F, Koch KT, de Winter RJ, Holierook M, Rensing BJWM, Timmers L, Eefting FD, Swaans MJ, Bouma BJ, Baan J.   +9 more
europepmc   +5 more sources

Update on Transcatheter Tricuspid Valve Replacement Therapies

Frontiers in Cardiovascular Medicine, 2021
Severe tricuspid regurgitation is relatively common, especially in the elderly, and portends poor survival. Neither medical therapy nor conventional surgery is efficacious for most patients.
Ythan H. Goldberg, Edwin Ho, Mei Chau, Azeem Latib   +3 more
doaj   +1 more source

Update on Transcatheter Treatment of Mitral and Tricuspid Valve Regurgitation. [PDF]

, 2023
PURPOSE OF REVIEW Mitral and tricuspid regurgitation represents a clinical challenge. They are associated with a poor prognosis, and many patients are not eligible for conventional surgery.
Boone, R.H., Muller, Olivier, Praz, F., Blanke, P., Sathananthan, J., Meier, David, Praz, Fabien, Cheung, A., Tzimas, Georgios, Webb, J.G., Boone, Robert H, Webb, John G, Akodad, Mariama, Tzimas, G., Meier, D., Wood, D.A., Blanke, Philipp, Cheung, Anson, Wood, David A, Akodad, M., Muller, O., Sathananthan, Janarthanan   +21 more
core   +2 more sources

Acute Tricuspid Leaflet Thrombus During Transcatheter Tricuspid Valve Repair. [PDF]

JACC Case Rep
Transcatheter tricuspid valve repair (TTVR) is a growing alternative for high-risk patients with tricuspid regurgitation; however, intraprocedural thrombotic events are rarely reported.An 80-year-old woman with chronic atrial fibrillation and severe functional tricuspid regurgitation underwent edge-to-edge TTVR with a 2-Pa device.
Nappa D, Salido-Tahoces ML, García-Martín A, Sánchez-Recalde Á, Fernández-Golfín C.   +4 more
europepmc   +4 more sources

Minimally invasive tricuspid valve surgery after failed transcatheter tricuspid valve repair. [PDF]

Ann Cardiothorac Surg
Akansel S, Kofler M, Dini M, Jacobs S, Falk V, Kempfert J.   +5 more
europepmc   +3 more sources

Transcatheter Tricuspid Valve Repair for Tricuspid Regurgitation: A Right-Sided Intervention With Left-Sided Benefits.

JACC: Cardiovascular Interventions
N. Fam, A. Patrascu
semanticscholar   +2 more sources

Transcatheter tricuspid valve interventions: Current status and future perspectives

Frontiers in Cardiovascular Medicine, 2022
The development of transcatheter therapies to treat valvular heart diseases has changed the rules of the game, particularly in the case of aortic stenosis and mitral regurgitation.
Alberto Alperi, Alberto Alperi, Marcel Almendárez, Marcel Almendárez, Rut Álvarez, Rut Álvarez, Cesar Moris, Cesar Moris, Cesar Moris, Victor Leon, Victor Leon, Iria Silva, Iria Silva, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Daniel Hernández-Vaquero, Isaac Pascual, Isaac Pascual, Isaac Pascual, Pablo Avanzas, Pablo Avanzas, Pablo Avanzas   +21 more
doaj   +1 more source